Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human monoclonal antibody against activin receptor type IIB

EU orphan designation number: EU/3/12/1035   
Active ingredient: Recombinant human monoclonal antibody against activin receptor type IIB
Indication: Treatment of inclusion body myositis
Sponsor: Novartis Europharm Limited
Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/08/2012 Centralised Orphan - Designation EMA/OD/046/12 (2012)5799 of 09/08/2012